A new dust testing methodology developed by University of Queensland researchers offers workers better protection from diseases such as black lung and silicosis.
Sino Biopharm’s invoX to restructure, likely cutting about 60 roles
Oncology and respiratory drug developer invoX Pharma is fine-tuning its pipeline and expects to cut about one-third of its employees, the company confirmed to …